Biogened Balance Sheet

Financials in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	6.32	6.07	7.51	-	-
Cash & Short-Term Investments	6.32	6.07	7.51	0	0
Cash Growth	4.18%	-19.22%	-	-	-
Accounts Receivable	17.04	14.82	13.26	16.33	20.4
Inventory	19.23	25.48	18.46	19.61	11.47
Other Current Assets	3.56	4.64	4.6	2.98	2.66
Total Current Assets	46.15	51.02	43.84	42.38	39.5
Net Property, Plant & Equipment	27.89	26.47	26.37	22.63	15.95
Other Intangible Assets	2.03	0.48	0.45	0.56	0.82
Other Long-Term Assets	10.83	8.44	7.85	5.71	4.74
Total Assets	86.9	86.4	78.51	71.28	61.02
Accounts Payable	13.57	14.71	15.17	-	-
Accrued Expenses	2.02	2.16	1.84	1.5	1.27
Short-Term Debt	6.43	2.22	11.3	2.53	10.59
Other Current Liabilities	3.97	4.15	4.3	5.38	4.82
Total Current Liabilities	23.53	21.07	30.63	17.95	22.11
Long-Term Debt	14.6	20.06	6.47	16.76	6.73
Other Long-Term Liabilities	2.63	2.82	3.64	3.06	1.36
Total Long-Term Liabilities	16.6	22.39	9.54	19.19	7.24
Total Liabilities	42.21	45.1	41.8	38.69	31.07
Common Stock	24.56	24.56	24.56	24.56	24.56
Additional Paid-in Capital	15.51	10.92	7.05	4.65	29.68
Retained Earnings	4.62	5.82	5.1	3.38	-24.29
Total Common Shareholders' Equity	44.7	41.3	36.71	32.59	29.95
Shareholders' Equity	42.21	45.1	41.8	38.69	31.07
Total Liabilities & Equity	86.9	86.4	78.51	71.28	61.02
Total Debt	21.03	22.27	17.76	19.29	17.32
Net Cash (Debt)	-14.7	-16.2	-10.25	-19.29	-17.32
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-5.99	-6.60	-4.17	-7.85	-7.05
Book Value	44.7	41.3	36.71	32.59	29.95
Book Value Per Share	18.20	16.81	14.94	13.27	12.19
Tangible Book Value	42.66	40.82	36.26	32.03	29.13
Tangible Book Value Per Share	17.37	16.62	14.76	13.04	11.86